Baidu
map

梅斯医学受邀参与第二届积水潭血管论坛

2016-04-26 MedSci MedSci原创

2016年4月22日,由北京积水潭医院血管外科主办的第二届积水潭血管论坛在北京·国家会议中心召开。来自相关领域的中外学者、专家齐聚一堂,共襄此次盛会。 本届积水潭血管论坛由北京积水潭医院血管外科刘建龙主任担任主席,同时本届论坛还邀请到了美国匹兹堡大学医疗中心的Rabih Chaer教授、纽约大学医学中心的Paul Gagne教授、台北慈济医院的吴典育教授以及领衔我国血管外

2016年4月22日,由北京积水潭医院血管外科主办的第二届积水潭血管论坛在北京·国家会议中心召开。来自相关领域的中外学者、专家齐聚一堂,共襄此次盛会。

本届积水潭血管论坛由北京积水潭医院血管外科刘建龙主任担任主席,同时本届论坛还邀请到了美国匹兹堡大学医疗中心的Rabih Chaer教授、纽约大学医学中心的Paul Gagne教授、台北慈济医院的吴典育教授以及领衔我国血管外科众多学会的知名专家教授汇聚一堂。梅斯医学(MedSci)也受邀参与了本届论坛。

 
北京积水潭医院血管外科刘建龙主任与梅斯医学市场经理Ada合影

 
美国匹兹堡大学医疗中心Rabih Chaer教授与梅斯医学市场经理Ada合影

纽约大学医学中心Paul Gagne教授与梅斯医学市场经理Ada合影

本届论坛的主题是“中美两国、海峡两岸VTE高端交流”。在论坛现场,学术氛围浓郁,来自中美两国、海峡两岸的血管外科专家们针对VTE的诊疗现状及焦点问题展开了一系列高规格、近距离交流,共同探讨了未来VTE诊治及研究方向。

第二届积水潭血管论坛参会点评及主题讨论专家列表

其中,刘建龙主任对中国血管外科发展的总结性发言,美国匹兹堡大学医疗中心的Rabih Chaer教授关于急性髂股静脉血栓治疗的介绍,纽约大学医学中心Paul Gagne教授关于慢性静脉疾病治疗的讲解等,都让在场的血管外科医生受益良多。祝福我国的血管外科事业发展越来越好,未来希望我国的VTE诊疗水平能走在世界前沿!

积水潭血管论坛主席——刘建龙主任

北京积水潭医院血管外科科主任

主要研究方向:血管外科专业

现任北京医学会血管外科分会、血栓与止血分会、创面修复分会常委,北京医师协会血管与腔内血管外科专家委员会常委,北京中西医结合血管外科学会常委,中华医学会组织工程与血管外科专业委员会常委,中国医师协会血管外科专业委员会常委,中华损伤与修复杂志、血管外科杂志、山东医药等杂志编委

关于“积水潭论坛”

“积水潭论坛”是北京积水潭医院每两年主办一届的大型学术会议,本着“求真务实、传承创新”的宗旨和“引领学术前沿”的责任,论坛已经从最初的骨科学术交流发展为多学科合作交流系列论坛。

关于梅斯医学

 梅斯医学(MedSci)是中国领先的医生互联网平台,拥有超过120万注册医生用户,主要从事临床研究、医生继续教育和培训,以及智慧医疗服务,旨在推动和加速临床医生的职业成长,改善医疗质量。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2041344, encodeId=bdad2041344b5, content=<a href='/topic/show?id=5dd1e51304a' target=_blank style='color:#2F92EE;'>#积水潭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75130, encryptionId=5dd1e51304a, topicName=积水潭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Nov 27 18:13:00 CST 2016, time=2016-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276812, encodeId=1b6b12e6812e5, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Apr 28 05:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83046, encodeId=bd8083046d5, content=学习了一下新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 27 09:13:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82990, encodeId=1688829907e, content=高水平论坛, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 27 07:06:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82938, encodeId=a68f829380b, content=积血潭, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6051708051, createdName=WEIXINee11cbcd, createdTime=Tue Apr 26 21:43:00 CST 2016, time=2016-04-26, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2041344, encodeId=bdad2041344b5, content=<a href='/topic/show?id=5dd1e51304a' target=_blank style='color:#2F92EE;'>#积水潭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75130, encryptionId=5dd1e51304a, topicName=积水潭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Nov 27 18:13:00 CST 2016, time=2016-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276812, encodeId=1b6b12e6812e5, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Apr 28 05:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83046, encodeId=bd8083046d5, content=学习了一下新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 27 09:13:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82990, encodeId=1688829907e, content=高水平论坛, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 27 07:06:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82938, encodeId=a68f829380b, content=积血潭, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6051708051, createdName=WEIXINee11cbcd, createdTime=Tue Apr 26 21:43:00 CST 2016, time=2016-04-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2041344, encodeId=bdad2041344b5, content=<a href='/topic/show?id=5dd1e51304a' target=_blank style='color:#2F92EE;'>#积水潭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75130, encryptionId=5dd1e51304a, topicName=积水潭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Nov 27 18:13:00 CST 2016, time=2016-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276812, encodeId=1b6b12e6812e5, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Apr 28 05:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83046, encodeId=bd8083046d5, content=学习了一下新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 27 09:13:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82990, encodeId=1688829907e, content=高水平论坛, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 27 07:06:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82938, encodeId=a68f829380b, content=积血潭, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6051708051, createdName=WEIXINee11cbcd, createdTime=Tue Apr 26 21:43:00 CST 2016, time=2016-04-26, status=1, ipAttribution=)]
    2016-04-27 1de11f7fm56(暂无匿称)

    学习了一下新知识

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2041344, encodeId=bdad2041344b5, content=<a href='/topic/show?id=5dd1e51304a' target=_blank style='color:#2F92EE;'>#积水潭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75130, encryptionId=5dd1e51304a, topicName=积水潭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Nov 27 18:13:00 CST 2016, time=2016-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276812, encodeId=1b6b12e6812e5, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Apr 28 05:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83046, encodeId=bd8083046d5, content=学习了一下新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 27 09:13:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82990, encodeId=1688829907e, content=高水平论坛, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 27 07:06:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82938, encodeId=a68f829380b, content=积血潭, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6051708051, createdName=WEIXINee11cbcd, createdTime=Tue Apr 26 21:43:00 CST 2016, time=2016-04-26, status=1, ipAttribution=)]
    2016-04-27 老段

    高水平论坛

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2041344, encodeId=bdad2041344b5, content=<a href='/topic/show?id=5dd1e51304a' target=_blank style='color:#2F92EE;'>#积水潭#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75130, encryptionId=5dd1e51304a, topicName=积水潭)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=21015, createdName=heli0118, createdTime=Sun Nov 27 18:13:00 CST 2016, time=2016-11-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276812, encodeId=1b6b12e6812e5, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=仁心济世, createdTime=Thu Apr 28 05:13:00 CST 2016, time=2016-04-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=83046, encodeId=bd8083046d5, content=学习了一下新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=195, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6b0d1671629, createdName=1de11f7fm56(暂无匿称), createdTime=Wed Apr 27 09:13:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82990, encodeId=1688829907e, content=高水平论坛, beContent=null, objectType=article, channel=null, level=null, likeNumber=136, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2d331664955, createdName=老段, createdTime=Wed Apr 27 07:06:00 CST 2016, time=2016-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=82938, encodeId=a68f829380b, content=积血潭, beContent=null, objectType=article, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e6051708051, createdName=WEIXINee11cbcd, createdTime=Tue Apr 26 21:43:00 CST 2016, time=2016-04-26, status=1, ipAttribution=)]
    2016-04-26 WEIXINee11cbcd

    积血潭

    0

相关资讯

景在平——红色医路 传奇人生

“有‘景’教授‘在’,患者就‘平’安!”——这是在百姓之间,广泛流传的对景教授的评价。 景在平教授现任第二军医大学附属长海医院普外科、血管外科主任、博士生导师;全国血管外科学组副组长、全军血管外科研究所所长;欧洲血管外科协会及国际腔内血管专家协会委员等多项职位。可谓“中国血管外科第一人”。 “世界上最值得尊敬的工作的是医生,医生中最值得尊敬的是外科医生,外科医生中最值得尊敬的是血管外科,血管外

导师梦工厂走进血管外科大咖

3月26日,中国微循环学会周围血管疾病专业委员会门脉高压学组成立大会在山东济南举行。本次会议由中国微循环学会周围血管疾病专业委员会、中华普通外科杂志、临床误诊误治杂志、中华糖尿病杂志、365血管网、山东大学附属济南市中心医院血管外科联合主办。北京协和医院血管外科主任医师郑月宏教授和北京友谊医院血管外科主任陈学明教授为大会名誉主席,山东大学附属济南市中心医院血管外科创始人孟庆义教授为大会执行主席。梅

导师梦工厂:走进血管外科大咖

2016年3月25-27日由中国微循环学会周围血管疾病专业委员会、北京友谊医院、北京积水潭医院、北京中日医院、中国中医科学院西苑医院、山东大学附属济南市中心医院联合主办主办的中国微循环学会周围血管疾病专业委员会门脉高压学组成立大会在上东济南隆重开幕。本次大会邀请国内知名专家就门静脉高压症相关问题进行专题学术讲座,秉承“以提高学术为宗旨,以门脉高压领域新理念、新技术与新进展为聚焦点“,推动我国门脉高

中国医师协会腔内血管学21个专委会在沪宣布成立

今天,由长海医院血管外科主办的2015年国际腔内血管学大会在上海隆重开幕。具有历史意义的是,在本届大会上成立了中国医师协会腔内血管学专业委员会领导下的21个专委会。在今天下午的大会上,进行了中国医师协会腔内血管学专业委员会各专委会的选举投票和成立仪式。中国医师协会腔内血管学专委会主任委员、长海医院血管外科主任景在平教授在致辞中指出:“分委会成立以后,将通过组织学术交流,邀请专家协助,进行本专业人员

袁良喜:下肢动脉硬化闭塞症诊治指南解读——间歇性跛行的治疗

在2015年国际腔内血管学大会上,来自长海医院血管外科的袁良喜博士为我们解读了下肢动脉硬化闭塞症诊治指南中关于间歇性跛行的治疗。 间歇性跛行的治疗流程 保守治疗(控制危险因素、运动治疗、药物治疗3-6个月),效果良好则随访;疗效不佳,影像学可见病变,要考虑是否适合腔内治疗,若不适合则行传统外科手术治疗。 间歇性跛行的运动和康复治疗 运动治疗必须在专业指导下进

Baidu
map
Baidu
map
Baidu
map